• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于无细胞蛋白质合成技术开发的重组蛋白疫苗用于斜带石斑鱼抗病毒性神经坏死病

Development of a Recombinant Protein Vaccine Based on Cell-Free Protein Synthesis for Sevenband Grouper Epinephelus septemfasciatus Against Viral Nervous Necrosis.

作者信息

Kim Jong-Oh, Kim Jae-Ok, Kim Wi-Sik, Oh Myung-Joo

机构信息

Department of Aqualife Medicine, College of Fisheries and Ocean Science, Chonnam National University, Yeosu 550-749, Republic of Korea.

出版信息

J Microbiol Biotechnol. 2015 Oct;25(10):1761-7. doi: 10.4014/jmb.1507.07004.

DOI:10.4014/jmb.1507.07004
PMID:26239013
Abstract

Sevenband grouper, Epinephelus septemfasciatus, is becoming an important aquaculture species in Korea. However, viral nervous necrosis disease is a large problem causing mass mortality in sevenband grouper aquaculture. Recombinant protein vaccines are one of the best methods to reduce these economic losses. However, the cell-based expression method mainly produces inclusion bodies and requires additional procedures. In this study, we expressed a recombinant viral coat protein of sevenband grouper nervous necrosis virus (NNV) using a cell-free protein synthesis system. The purified recombinant NNV coat protein (rNNV-CP) was injected into sevenband grouper at different doses followed by a NNV challenge. Nonimmunized fish in the first trial (20 μg/fish) began to die 5 days post-challenge and reached 70% cumulative mortality. In contrast, immunized fish also starting dying 5 days postchallenge but lower cumulative mortality (10%) was observed. Cumulative morality in the second trial with different doses (20, 4, and 0.8 μg/fish) was 10%, 40%, and 50%, respectively. These results suggest that rNNV-CP can effectively immunize sevenband grouper depending on the dose administered. This study provides a new approach to develop a recombinant vaccine against NNV infection for sevenband grouper.

摘要

七带石斑鱼(Epinephelus septemfasciatus)正成为韩国重要的水产养殖品种。然而,病毒性神经坏死病是七带石斑鱼水产养殖中导致大规模死亡的一个大问题。重组蛋白疫苗是减少这些经济损失的最佳方法之一。然而,基于细胞的表达方法主要产生包涵体,并且需要额外的步骤。在本研究中,我们使用无细胞蛋白质合成系统表达了七带石斑鱼神经坏死病毒(NNV)的重组病毒衣壳蛋白。将纯化的重组NNV衣壳蛋白(rNNV-CP)以不同剂量注射到七带石斑鱼体内,随后进行NNV攻毒。第一次试验中未免疫的鱼(20μg/鱼)在攻毒后5天开始死亡,累积死亡率达到70%。相比之下,免疫的鱼在攻毒后5天也开始死亡,但观察到较低的累积死亡率(10%)。第二次试验中不同剂量(20、4和0.8μg/鱼)的累积死亡率分别为10%、40%和50%。这些结果表明,rNNV-CP可以根据给药剂量有效地免疫七带石斑鱼。本研究为开发针对七带石斑鱼NNV感染的重组疫苗提供了一种新方法。

相似文献

1
Development of a Recombinant Protein Vaccine Based on Cell-Free Protein Synthesis for Sevenband Grouper Epinephelus septemfasciatus Against Viral Nervous Necrosis.基于无细胞蛋白质合成技术开发的重组蛋白疫苗用于斜带石斑鱼抗病毒性神经坏死病
J Microbiol Biotechnol. 2015 Oct;25(10):1761-7. doi: 10.4014/jmb.1507.07004.
2
Potentiality of a live vaccine with nervous necrosis virus (NNV) for sevenband grouper Epinephelus septemfasciatus at a low rearing temperature.在低温养殖条件下,神经坏死病毒(NNV)活疫苗对七带石斑鱼(Epinephelus septemfasciatus)的潜力。
Vaccine. 2012 Feb 1;30(6):1056-63. doi: 10.1016/j.vaccine.2011.12.033. Epub 2011 Dec 15.
3
Efficacy of live NNV immersion vaccine immunized at low temperature in sevenband grouper, Epinephelus septemfasciatus.低温条件下浸泡免疫新型神经坏死病毒活疫苗对七带石斑鱼的免疫效果。
Virus Res. 2021 Jan 15;292:198227. doi: 10.1016/j.virusres.2020.198227. Epub 2020 Nov 10.
4
Field tests of Poly(I:C) immunization with nervous necrosis virus (NNV) in sevenband grouper, Epinephelus septemfasciatus (Thunberg).七带石斑鱼(Epinephelus septemfasciatus)神经坏死病毒(NNV)与聚肌胞免疫的田间试验。
J Fish Dis. 2012 Mar;35(3):187-91. doi: 10.1111/j.1365-2761.2011.01334.x. Epub 2012 Jan 12.
5
Novel subunit vaccine with linear array epitope protect giant grouper against nervous necrosis virus infection.新型含线性表位亚单位疫苗保护巨石斑鱼抵抗神经坏死病毒感染。
Fish Shellfish Immunol. 2018 Mar;74:551-558. doi: 10.1016/j.fsi.2018.01.029.
6
Assessment of the sevenband grouper Epinephelus septemfasciatus with a live nervous necrosis virus (NNV) vaccine at natural seawater temperature.评估在自然海水温度下,使用神经坏死病毒(NNV)活疫苗对七带石斑鱼(Epinephelus septemfasciatus)的效果。
Vaccine. 2013 Apr 12;31(16):2025-7. doi: 10.1016/j.vaccine.2013.02.049. Epub 2013 Mar 7.
7
Neutralizing antibody levels for protection against betanodavirus infection in sevenband grouper, Epinephelus septemfasciatus (Thunberg), immunized with an inactivated virus vaccine.用灭活病毒疫苗免疫的七带石斑鱼(Epinephelus septemfasciatus,Thunberg)中针对预防神经坏死病毒感染的中和抗体水平。
J Fish Dis. 2009 Sep;32(9):767-75. doi: 10.1111/j.1365-2761.2009.01054.x. Epub 2009 May 28.
8
Anti-viral effects of interferon administration on sevenband grouper, Epinephelus septemfasciatus.干扰素给药对七带石斑鱼(Epinephelus septemfasciatus)的抗病毒作用。
Fish Shellfish Immunol. 2011 Apr-May;30(4-5):1064-71. doi: 10.1016/j.fsi.2011.02.003. Epub 2011 Feb 18.
9
Lack of nervous necrosis virus (NNV) neutralizing antibodies in convalescent sevenband grouper Hyporthodus septemfasciatus after NNV infection.神经坏死病毒(NNV)感染后,恢复期七带石斑鱼(Hyporthodus septemfasciatus)体内缺乏中和抗体。
Vaccine. 2018 Mar 27;36(14):1863-1870. doi: 10.1016/j.vaccine.2018.02.063. Epub 2018 Mar 2.
10
Oral vaccination through voluntary consumption of the convict grouper Epinephelus septemfasciatus with yeast producing the capsid protein of red-spotted grouper nervous necrosis virus.通过自愿投喂表达斜带石斑鱼神经坏死病毒衣壳蛋白的酵母,对点带石斑鱼进行口服疫苗接种。
Vet Microbiol. 2017 May;204:159-164. doi: 10.1016/j.vetmic.2017.04.022. Epub 2017 Apr 24.

引用本文的文献

1
BEI Inactivated Vaccine Induces Innate and Adaptive Responses and Elicits Partial Protection upon Reassortant Betanodavirus Infection in Senegalese Sole.BEI灭活疫苗可诱导先天和适应性反应,并在塞内加尔鳎感染重组β诺达病毒时引发部分保护作用。
Vaccines (Basel). 2021 May 4;9(5):458. doi: 10.3390/vaccines9050458.
2
Integration of cell-free protein synthesis and purification in one microfluidic chip for on-demand production of recombinant protein.将无细胞蛋白质合成与纯化集成于一个微流控芯片中,用于按需生产重组蛋白。
Biomicrofluidics. 2018 Sep 13;12(5):054102. doi: 10.1063/1.5042307. eCollection 2018 Sep.